Physicists Take on Challenge Of Showing How Proteins Fold

How proteins fold is a central mystery of the life process that for decades has eluded explanation. But biologists are getting help on the problem nowadays from physicists, who bring quantitative theorems and new technologies to the task of showing how one-dimensional amino acid sequences determine the three-dimensional shapes of proteins. Such knowledge could guide structure-based design of drugs to treat a range of diseases now thought to be caused by misshapen proteins. "We're just beginnin

Written bySteve Bunk
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

How proteins fold is a central mystery of the life process that for decades has eluded explanation. But biologists are getting help on the problem nowadays from physicists, who bring quantitative theorems and new technologies to the task of showing how one-dimensional amino acid sequences determine the three-dimensional shapes of proteins. Such knowledge could guide structure-based design of drugs to treat a range of diseases now thought to be caused by misshapen proteins.

"We're just beginning," says Stanford University's Steven Chu, cowinner of the 1997 Nobel Prize in physics, who has recently turned his efforts toward the protein folding question. "Everyone is just beginning. The interesting thing is, straight off, you see things you don't understand."

Steven Chu Chu gave the keynote address at the third international symposium on biological physics, held recently in Santa Fe, N.M. Speakers from the United States and a dozen foreign countries focused on a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies